Taysha Gene Therapies (TSHA) Leases: 2022-2025
Historic Leases for Taysha Gene Therapies (TSHA) over the last 3 years, with Sep 2025 value amounting to $7.5 million.
- Taysha Gene Therapies' Leases fell 14.00% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year decrease of 14.00%. This contributed to the annual value of $8.4 million for FY2024, which is 12.53% down from last year.
- Taysha Gene Therapies' Leases amounted to $7.5 million in Q3 2025, which was down 3.99% from $7.8 million recorded in Q2 2025.
- In the past 5 years, Taysha Gene Therapies' Leases registered a high of $10.9 million during Q4 2022, and its lowest value of $7.5 million during Q3 2025.
- Over the past 3 years, Taysha Gene Therapies' median Leases value was $9.0 million (recorded in 2024), while the average stood at $9.0 million.
- Data for Taysha Gene Therapies' Leases shows a maximum YoY fell of 14.00% (in 2025) over the last 5 years.
- Over the past 4 years, Taysha Gene Therapies' Leases (Quarterly) stood at $10.9 million in 2022, then dropped by 12.44% to $9.6 million in 2023, then decreased by 12.53% to $8.4 million in 2024, then decreased by 14.00% to $7.5 million in 2025.
- Its Leases stands at $7.5 million for Q3 2025, versus $7.8 million for Q2 2025 and $8.1 million for Q1 2025.